ng thi, hp cht cng lm gim s cng thng, stress ko di v ci thin cht lng gic ng l tt hn
With respect to the substantial similarity criteria, the applicant believes that CYTALUX is not substantially similar to other currently available technologies because there are no other optical imaging agents with the same active ingredient, nor the same mechanism of action for the same indication of ovarian cancer, and that therefore, the technology meets the newness criterion
It should be: - Clear not hazy or cloudy - Colorless no yellow, brown, or pink tint - Free of visible particles, fibers, or floaters - Fully dissolved no powder remaining on glass If any of these criteria are not met, **do not inject.** Contact your compounding pharmacy
10.2174/1381612824666180712110447 [DOI] [PubMed] [Google Scholar] Sever, A
A.KollefM.et al